Apyx medical corporation to release third quarter of fiscal year 2024 financial results on november 8, 2024

Clearwater, fla., oct. 25, 2024 (globe newswire) -- apyx® medical corporation (nasdaq:apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as renuvion®, today announced that financial results for the third quarter of fiscal year 2024 will be released before the market opens on friday, november 8th.
APYX Ratings Summary
Quant
APYX Quant Ranking
Sector
Industry
Quant Rating
Quant Score